Pyogenic granuloma (PG) is a common, acquired, benign vascular neoplasm of the skin and mucous membranes. It occurs most often in children and adolescents. First-line treatment options for PG are based on destructive approaches. Pain, permanent scarring, and pigmentation are potential complications of these therapies.
Neri, I., Baraldi, C., Balestri, R., Piraccini, B.M., Patrizi, A. (2018). Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: An open-label study in 22 children. PEDIATRIC DERMATOLOGY, 35(1), 117-120 [10.1111/pde.13372].
Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: An open-label study in 22 children
Neri, Iria;Baraldi, Carlotta;Balestri, Riccardo;Piraccini, Bianca Maria;Patrizi, Annalisa
2018
Abstract
Pyogenic granuloma (PG) is a common, acquired, benign vascular neoplasm of the skin and mucous membranes. It occurs most often in children and adolescents. First-line treatment options for PG are based on destructive approaches. Pain, permanent scarring, and pigmentation are potential complications of these therapies.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
